Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD 0.210
+0.010 (5.00%)
Mar 10, 2026, 1:54 PM AEST
Argenica Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Cash & Equivalents | 5.04 | 10.56 | 15.91 | 9.29 | 8.91 | 7.14 | Upgrade
|
| Short-Term Investments | - | - | - | 0.05 | - | - | Upgrade
|
| Cash & Short-Term Investments | 5.04 | 10.56 | 15.91 | 9.34 | 8.91 | 7.14 | Upgrade
|
| Cash Growth | -66.59% | -33.67% | 70.39% | 4.76% | 24.78% | 1989.04% | Upgrade
|
| Other Receivables | 0.11 | 0.42 | 0.37 | 0.15 | 0.07 | 0.08 | Upgrade
|
| Receivables | 0.11 | 0.42 | 0.37 | 0.15 | 0.07 | 0.08 | Upgrade
|
| Prepaid Expenses | 0.05 | 0.06 | 0.09 | 0.05 | 0.06 | 0.05 | Upgrade
|
| Total Current Assets | 5.2 | 11.04 | 16.38 | 9.54 | 9.04 | 7.27 | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 5.2 | 11.04 | 16.38 | 9.54 | 9.04 | 7.27 | Upgrade
|
| Accounts Payable | 1.28 | 2.88 | 1.4 | 1.14 | 0.67 | 0.37 | Upgrade
|
| Accrued Expenses | 0.08 | 0.27 | 0.3 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Current Unearned Revenue | 0.4 | 0.62 | 0.7 | 0.66 | - | - | Upgrade
|
| Other Current Liabilities | - | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Total Current Liabilities | 1.76 | 3.8 | 2.43 | 1.87 | 0.74 | 0.43 | Upgrade
|
| Total Liabilities | 1.76 | 3.8 | 2.43 | 1.87 | 0.74 | 0.43 | Upgrade
|
| Common Stock | 29.66 | 29.63 | 28.43 | 16.62 | 13.07 | 8.05 | Upgrade
|
| Retained Earnings | -26.55 | -22.73 | -15.69 | -10.32 | -5.5 | -1.41 | Upgrade
|
| Comprehensive Income & Other | 0.34 | 0.34 | 1.21 | 1.37 | 0.75 | 0.21 | Upgrade
|
| Shareholders' Equity | 3.44 | 7.24 | 13.95 | 7.67 | 8.31 | 6.85 | Upgrade
|
| Total Liabilities & Equity | 5.2 | 11.04 | 16.38 | 9.54 | 9.04 | 7.27 | Upgrade
|
| Net Cash (Debt) | 5.04 | 10.56 | 15.91 | 9.34 | 8.91 | 7.14 | Upgrade
|
| Net Cash Growth | -66.59% | -33.67% | 70.39% | 4.76% | 24.78% | 1989.04% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.08 | 0.15 | 0.13 | 0.12 | 0.20 | Upgrade
|
| Filing Date Shares Outstanding | 128.46 | 128.46 | 127.13 | 99.15 | 86.92 | 73.17 | Upgrade
|
| Total Common Shares Outstanding | 128.46 | 128.45 | 123.7 | 98.35 | 86.92 | 73.17 | Upgrade
|
| Working Capital | 3.44 | 7.24 | 13.95 | 7.67 | 8.31 | 6.85 | Upgrade
|
| Book Value Per Share | 0.03 | 0.06 | 0.11 | 0.08 | 0.10 | 0.09 | Upgrade
|
| Tangible Book Value | 3.44 | 7.24 | 13.95 | 7.67 | 8.31 | 6.85 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.06 | 0.11 | 0.08 | 0.10 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.